Role of OxyR in P. aeruginosa Biofilm Resistance to H202
OxyR 在铜绿假单胞菌生物膜 H2O2 抗性中的作用
基本信息
- 批准号:7271227
- 负责人:
- 金额:$ 28.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-08-01 至 2009-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAerobicAminoglycosidesAnimal ModelAnimalsAntibiotic ResistanceAntibioticsBacteriaBacterial InfectionsBiocideBiological ModelsBloodBurn injuryChronic PhaseClinicalCystic FibrosisDataDevelopmentDiseaseDrug Delivery SystemsEventFocal InfectionGoalsGrowthHumanHydrogen PeroxideInfectionKnowledgeLesionLightLungMediatingMicrobial BiofilmsModelingMucous body substanceOrganismPhagocytesPhaseProteinsPseudomonas aeruginosaRangeRattusRefractoryResistanceRespiratory BurstRoleStagingSystemic infectionTestingThickTobramycinTrans-ActivatorsVacuoleVirulenceVirulentantimicrobialbasecystic fibrosis airwaykillingsmouse modelmutantneutrophilpathogenresponse
项目摘要
DESCRIPTION (provided by applicant): In cystic fibrosis (CF) airway disease, there is compelling evidence for two distinct clinical stages, an oxidative phase (early-stage CF) and an anaerobic phase (chronic, late-stage CF). Within the thick mucus lining the CF airways, the bacteria grow as a "biofilm," a form of development that affords organisms the luxury of enhanced resistance to antibiotics and biocides. The early oxidative phase is based upon a rapid and dramatic influx of neutrophils to the upper airways, an event triggered by bacterial infection. When stimulated, these professional phagocytes mount a potent "respiratory burst," an antimicrobial product from which is hydrogen peroxide (H202). In fact, neutrophils can generate millimolar levels of H202 within the phagolysomal vacuole. In contrast, H202 levels in blood are nearly 1000-fold lower. Surprisingly, a mutant of the major CF pathogen, Pseudomonas aeruginosa, lacking the H202-responsive transactivator, OxyR, is exquisitely sensitive to H202 and the bacteria perish even in the presence of blood H202 levels (micromolar range). Were OxyR to be compromised during human infection, bacteria would be unable to elicit a systemic infection because they would die via H202-mediated killing. Therefore, the goal of this proposal is to determine if OxyR of P. aeruginosa could serve as a drug target during various P. aeruginosa infections. The goals of this proposal are to (i) define a role for OxyR in animal virulence and resistance to human neutrophils, (ii) define the lesions that evoke exquisite sensitivity to H202 in the OxyR mutant and what OxyR-controlled gene products contribute to maximal or minimal protection, and (iii) determine whether OxyR is critical for survival of biofilm bacteria to H202 and aminoglycosides.
描述(由申请人提供):在囊性纤维化 (CF) 气道疾病中,有令人信服的证据表明两个不同的临床阶段:氧化阶段(早期 CF)和厌氧阶段(慢性、晚期 CF)。在 CF 气道内衬的浓稠粘液中,细菌以“生物膜”的形式生长,这种发育形式使生物体能够增强对抗生素和杀菌剂的抵抗力。早期氧化阶段是基于中性粒细胞快速而剧烈地流入上呼吸道,这是由细菌感染引发的事件。当受到刺激时,这些专业吞噬细胞会产生强大的“呼吸爆发”,这是一种抗菌产物,其中的过氧化氢(H2O2)。事实上,中性粒细胞可以在吞噬溶酶体液泡内产生毫摩尔水平的H2O2。相比之下,血液中的 H202 水平低了近 1000 倍。令人惊讶的是,主要 CF 病原体铜绿假单胞菌的突变体缺乏 H2O2 响应反式激活因子 OxyR,对 H2O2 极其敏感,并且即使在血液 H2O2 水平(微摩尔范围)存在的情况下,细菌也会死亡。如果 OxyR 在人类感染过程中受到损害,细菌将无法引发全身感染,因为它们会通过 H2O2 介导的杀伤作用而死亡。因此,本提案的目标是确定铜绿假单胞菌的 OxyR 是否可以作为各种铜绿假单胞菌感染期间的药物靶点。该提案的目标是 (i) 确定 OxyR 在动物毒力和对人类中性粒细胞的抵抗力中的作用,(ii) 确定 OxyR 突变体中引起对 H2O2 高度敏感性的病变,以及哪些 OxyR 控制的基因产物有助于最大或最小的保护,以及 (iii) 确定 OxyR 是否对于生物膜细菌对 H202 和 H2O2 的生存至关重要。 氨基糖苷类。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Investigating the predictability of essential genes across distantly related organisms using an integrative approach.
- DOI:10.1093/nar/gkq784
- 发表时间:2011-02
- 期刊:
- 影响因子:14.9
- 作者:Deng J;Deng L;Su S;Zhang M;Lin X;Wei L;Minai AA;Hassett DJ;Lu LJ
- 通讯作者:Lu LJ
Differential roles of OxyR-controlled antioxidant enzymes alkyl hydroperoxide reductase (AhpCF) and catalase (KatB) in the protection of Pseudomonas aeruginosa against hydrogen peroxide in biofilm vs. planktonic culture.
- DOI:10.1111/j.1574-6968.2009.01605.x
- 发表时间:2009-06
- 期刊:
- 影响因子:2.1
- 作者:Panmanee W;Hassett DJ
- 通讯作者:Hassett DJ
The OxyR-regulated phnW gene encoding 2-aminoethylphosphonate:pyruvate aminotransferase helps protect Pseudomonas aeruginosa from tert-butyl hydroperoxide.
- DOI:10.1371/journal.pone.0189066
- 发表时间:2017
- 期刊:
- 影响因子:3.7
- 作者:Panmanee W;Charoenlap N;Atichartpongkul S;Mahavihakanont A;Whiteside MD;Winsor G;Brinkman FSL;Mongkolsuk S;Hassett DJ
- 通讯作者:Hassett DJ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANIEL J. HASSETT其他文献
DANIEL J. HASSETT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANIEL J. HASSETT', 18)}}的其他基金
An innovative treatment for Pneumocystis pneumonia
肺孢子菌肺炎的创新治疗方法
- 批准号:
8873445 - 财政年份:2015
- 资助金额:
$ 28.68万 - 项目类别:
Mechanism Underlying Nitrite Sensitivity of Mucoid Pseudomonas in COPD
COPD 中粘液假单胞菌亚硝酸盐敏感性的机制
- 批准号:
7931027 - 财政年份:2010
- 资助金额:
$ 28.68万 - 项目类别:
Mechanism Underlying Nitrite Sensitivity of Mucoid Pseudomonas in COPD
COPD 中粘液假单胞菌亚硝酸盐敏感性的机制
- 批准号:
8391607 - 财政年份:2010
- 资助金额:
$ 28.68万 - 项目类别:
Mechanism Underlying Nitrite Sensitivity of Mucoid Pseudomonas in COPD
COPD 中粘液假单胞菌亚硝酸盐敏感性的机制
- 批准号:
8196343 - 财政年份:2010
- 资助金额:
$ 28.68万 - 项目类别:
Role of OxyR in P. aeruginosa Biofilm Resistance to H202
OxyR 在铜绿假单胞菌生物膜 H2O2 抗性中的作用
- 批准号:
6831086 - 财政年份:2004
- 资助金额:
$ 28.68万 - 项目类别:
Role of OxyR in P. aeruginosa Biofilm Resistance to H202
OxyR 在铜绿假单胞菌生物膜 H2O2 抗性中的作用
- 批准号:
6931186 - 财政年份:2004
- 资助金额:
$ 28.68万 - 项目类别:
Role of OxyR in P. aeruginosa Biofilm Resistance to H202
OxyR 在铜绿假单胞菌生物膜 H2O2 抗性中的作用
- 批准号:
7111811 - 财政年份:2004
- 资助金额:
$ 28.68万 - 项目类别:
Proteogenome of Anaerobic P. aeruginosa in CF Mucus
CF 粘液中厌氧铜绿假单胞菌的蛋白质组
- 批准号:
6609992 - 财政年份:2003
- 资助金额:
$ 28.68万 - 项目类别:
B.pseudomallei bioterrorism and quorum sensing
B.pseudomallei 生物恐怖主义和群体感应
- 批准号:
6659914 - 财政年份:2002
- 资助金额:
$ 28.68万 - 项目类别:
B.pseudomallei bioterrorism and quorum sensing
B.pseudomallei 生物恐怖主义和群体感应
- 批准号:
6556955 - 财政年份:2002
- 资助金额:
$ 28.68万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 28.68万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 28.68万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 28.68万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 28.68万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 28.68万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 28.68万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 28.68万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 28.68万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 28.68万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 28.68万 - 项目类别:
Research Grant














{{item.name}}会员




